Award
Delivery Order #SPE2DP26F3429
Hydromorphone Pharmaceutical Delivery Order under Definitive Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$111.99
Ceiling
$111.99
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 09, 2026
Identifier
SPE2DP26F3429
NAICS
424210
This award is a delivery order contract issued under a long-term definitive pharmaceutical supply contract to DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceutical products. It involves the procurement of hydromorphone hydrochloride, a critical opioid medication used for pain management. This order supports the agency's ongoing commitment to maintaining essential drug inventories to meet public health demands. The scope of work covers the delivery of specific pharmaceutical products as part of a broader portfolio managed under the parent indefinite delivery vehicle contract. The contract is competitively procured as part of the strategic supply vehicle without indication of a sole-source justification. The award period is a single-day performance timeline, consistent with specific delivery scheduling. This delivery order complements the overarching contract that secures a continuous and diversified supply of essential medications for federal health agencies.
Description
8511966094!HYDROMORPHONE HYDRO